DK2327792T3 - Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme - Google Patents

Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme

Info

Publication number
DK2327792T3
DK2327792T3 DK10188070.6T DK10188070T DK2327792T3 DK 2327792 T3 DK2327792 T3 DK 2327792T3 DK 10188070 T DK10188070 T DK 10188070T DK 2327792 T3 DK2327792 T3 DK 2327792T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
detection
autoimmune diseases
provides methods
Prior art date
Application number
DK10188070.6T
Other languages
English (en)
Inventor
Alexander Abbas
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK2327792T3 publication Critical patent/DK2327792T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK10188070.6T 2005-08-05 2006-08-02 Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme DK2327792T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70620505P 2005-08-05 2005-08-05
EP06789292A EP1945800B1 (en) 2005-08-05 2006-08-02 Methods and compositions for detecting autoimmune disorders

Publications (1)

Publication Number Publication Date
DK2327792T3 true DK2327792T3 (da) 2014-01-13

Family

ID=37663302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10188070.6T DK2327792T3 (da) 2005-08-05 2006-08-02 Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme

Country Status (11)

Country Link
US (3) US20070092890A1 (da)
EP (2) EP1945800B1 (da)
AT (1) ATE549416T1 (da)
AU (1) AU2006278561C1 (da)
CA (1) CA2614455A1 (da)
DK (1) DK2327792T3 (da)
ES (2) ES2432026T3 (da)
PL (1) PL2327792T3 (da)
PT (1) PT2327792E (da)
SI (1) SI2327792T1 (da)
WO (1) WO2007019219A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080057503A1 (en) 2006-04-24 2008-03-06 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
EP2712930A3 (en) * 2006-12-06 2014-04-23 MedImmune, LLC Interferon alpha-induced pharmacodynamic markers
US20100261172A1 (en) * 2007-05-03 2010-10-14 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
CA2686861A1 (en) 2007-05-03 2008-11-13 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
WO2008144761A2 (en) 2007-05-21 2008-11-27 Genentech, Inc. Methods and compositions for identifying and treating lupus
NZ585064A (en) * 2007-11-05 2012-08-31 Medimmune Llc Methods of treating scleroderma
KR20110005783A (ko) * 2008-02-08 2011-01-19 메디뮨 엘엘씨 질환 마커 및 그의 용도
CA2772921A1 (en) * 2009-09-03 2011-03-10 Medimmune, Llc Type 1 interferon diagnostic
US9111179B2 (en) 2009-09-18 2015-08-18 Rutgers, The State University Of New Jersey High-throughput biomarker segmentation utilizing hierarchical normalized cuts
CN113025703A (zh) 2009-10-07 2021-06-25 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
US8824769B2 (en) * 2009-10-16 2014-09-02 General Electric Company Process and system for analyzing the expression of biomarkers in a cell
ES2372762B1 (es) * 2010-07-02 2012-11-28 Consejo Superior De Investigaciones Científicas (Csic) Método y kit para la detección de la activación de interferón y la respuesta inflamatoria independiente de interferón.
US20130216557A1 (en) * 2010-08-14 2013-08-22 Biogen Idec Ma Inc. Ltbr blockade: methods for optimizing therapeutic responsiveness of patients
WO2016179268A1 (en) * 2015-05-05 2016-11-10 University Of Florida Research Foundation, Inc. Diagnostic microarray, system and method

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
AU3485999A (en) * 1998-04-10 1999-11-01 Mayo Foundation For Medical Education And Research Neo-tryptophan
WO2001075166A2 (en) 2000-03-31 2001-10-11 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
US20030148298A1 (en) * 2001-04-03 2003-08-07 O''toole Margot Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
JP2006503587A (ja) * 2002-05-16 2006-02-02 バンダービルト・ユニバーシティ 自己免疫疾患の予測方法
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
JP2011516026A (ja) * 2002-11-26 2011-05-26 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
WO2005123113A2 (en) * 2004-06-14 2005-12-29 Intermune, Inc. Interferon compositions and methods of use thereof
WO2006020899A2 (en) * 2004-08-13 2006-02-23 Metrigenix Corporation Markers for autoimmune disease detection
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus

Also Published As

Publication number Publication date
WO2007019219A2 (en) 2007-02-15
AU2006278561A1 (en) 2007-02-15
PL2327792T3 (pl) 2014-03-31
EP1945800A2 (en) 2008-07-23
AU2006278561B2 (en) 2012-11-01
ES2383966T3 (es) 2012-06-27
ATE549416T1 (de) 2012-03-15
WO2007019219A3 (en) 2007-05-31
EP2327792B1 (en) 2013-10-02
SI2327792T1 (sl) 2013-12-31
HK1158700A1 (en) 2012-07-20
PT2327792E (pt) 2013-11-21
EP1945800B1 (en) 2012-03-14
EP2327792A1 (en) 2011-06-01
US20070092890A1 (en) 2007-04-26
US20100279298A1 (en) 2010-11-04
AU2006278561C1 (en) 2013-05-02
CA2614455A1 (en) 2007-02-15
EP2327792B9 (en) 2013-12-18
US20080318800A1 (en) 2008-12-25
ES2432026T3 (es) 2013-11-29

Similar Documents

Publication Publication Date Title
DK2402758T3 (da) Fremgangsmåder og anvendelser til identificering af oprindelsen af et karcinom med ukendt primær oprindelse
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
DK1966393T3 (da) Fremgangsmåde til AFLP-baseret påvisning af polymorfisme med høj omsætning
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
DK1632168T3 (da) Indretning til detektion af formen af et endoskop
DK2135603T3 (da) Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet
NO20073368L (no) Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav
DE602006016150D1 (de) Vorbeugung von krankheiten bei kaiserschnitt-babies
DK1836169T3 (da) Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
DK2902690T3 (da) Anomalidetektor til rørledninger
DK1879573T3 (da) Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
FI20050727L (fi) Vieraiden hiukkasten tribologinen analyysijärjestelmä
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
ATE476655T1 (de) Doxorubicin-immuntest
DE602006009573D1 (de) Vorspannungsschaltung
DK1896077T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
NL1032881A1 (nl) Optisch monsterkarakteriseringssysteem.
NO20064896L (no) Fremgangsmater for behandling av autoimmune og inflammatoriske sykdommer
DK1907374T3 (da) Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
EP1910272A4 (en) Renin Inhibitors